How Can We Help?
Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.
In 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa.[1] GSK had formerly made use of the Corixa's MPL (Monophosphoryl lipid A, a derivative of the lipid A molecule), an adjuvant in some of their vaccines.
External links
- "Corixa Corporation - powering the immune system". Archived from the original on 2006-03-01.
References
- ^ "Glaxo to acquire Corixa for $300 million". Market Watch. April 29, 2005.
Recent Comments